LSU grad files for patent, working with FDA on drug to stop COVID-19

ATLANTA - A Baton Rouge native and LSU grad said scientists working for her company have found a drug that is showing promise in laboratories at blocking the continued spread of COVID-19.Darnisha Harrison went to Baton Rouge High and LSU before moving to Georgia. She is the CEO and founder of Ennaid Therapeutics, a pharmaceutical company that develops antiviral drugs. Two weeks ago, she said a patent was filed after scientists discovered a drug showed strong scientific evidence of blocking two